Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Monitoring Natural SARS-CoV-2 Infection in Lions ( Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses
Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series.
Piglets inoculated by different routes are not susceptible to SARS-CoV-2, but those inoculated parenterally were immunized against the virus.
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.
When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses.